FDA Inspection
Asentral Inc. IRBAsentral Inc. IRB – FDA Inspection, May 14, 2013
Record Details
This FDA Inspection record concerns Asentral Inc. IRB, with an inspection on May 14, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Asentral Inc. IRB
- Inspection Date
- May 14, 2013
- Product Type
- Drugs
View Company Profile
ID · ebb0501c-739e-4e1d-97c9-0cdff7f4166b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 832470
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 56.115(a)(5)List of members
- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 50.55(b)Adequate assent of children; items to consider
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Asentral Inc. IRB
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2019 | NAI | Bioresearch Monitoring |
Other documents for Asentral Inc. IRB
- FDA Inspection 1109738 - 2019-10-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.